These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29155153)

  • 21. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms through which a small protein and lipid preload improves glucose tolerance.
    Tricò D; Baldi S; Tulipani A; Frascerra S; Macedo MP; Mari A; Ferrannini E; Natali A
    Diabetologia; 2015 Nov; 58(11):2503-12. PubMed ID: 26224101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy.
    Lencioni C; Resi V; Romero F; Lupi R; Volpe L; Bertolotto A; Ghio A; Del Prato S; Marchetti P; Di Cianni G
    J Endocrinol Invest; 2011 Oct; 34(9):e287-90. PubMed ID: 21666414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of islet cell function, insulin sensitivity, and incretin axis between Asian-Indians with either impaired fasting glucose or impaired glucose tolerance, and normal healthy controls.
    Roy A; Kamalanathan S; Sahoo J; Kar SS; Naik D; Narayanan N; Merugu C; Patel D
    Diabetes Res Clin Pract; 2021 Jun; 176():108846. PubMed ID: 33951481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.
    Morínigo R; Lacy AM; Casamitjana R; Delgado S; Gomis R; Vidal J
    Obes Surg; 2006 Dec; 16(12):1594-601. PubMed ID: 17217635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
    Bonde L; Vilsbøll T; Nielsen T; Bagger JI; Svare JA; Holst JJ; Larsen S; Knop FK
    Diabetes Obes Metab; 2013 Aug; 15(8):713-20. PubMed ID: 23406269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
    Aulinger BA; Vahl TP; Prigeon RL; D'Alessio DA; Elder DA
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E774-81. PubMed ID: 26979523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.
    Huang X; Li S; Yang M; Fu X; Li H; Yan T; Liu Y; Chen L; Lan L; Li L; Zhong X
    Diabetes Res Clin Pract; 2018 Apr; 138():246-252. PubMed ID: 29408704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic.
    Tura A; Muscelli E; Gastaldelli A; Ferrannini E; Mari A
    Diabetologia; 2014 Jun; 57(6):1199-203. PubMed ID: 24658843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
    Muscelli E; Mari A; Casolaro A; Camastra S; Seghieri G; Gastaldelli A; Holst JJ; Ferrannini E
    Diabetes; 2008 May; 57(5):1340-8. PubMed ID: 18162504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes.
    Lee S; Yabe D; Nohtomi K; Takada M; Morita R; Seino Y; Hirano T
    Endocr J; 2010; 57(2):119-26. PubMed ID: 19881250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.